NOVERA RETATRUTIDE: THE NEW HOPE FOR WEIGHT MANAGEMENT?

Emerging clinical evidence suggests that Novera Retatrutide, a twin-action medication from Novo Nordisk, could offer a meaningful advance in weight control. Differing from many existing drugs, Retatrutide targets both the GLP-1 hormone and the GIP hormone, potentially leading to greater losses in